| Literature DB >> 31294139 |
Sang Hoon Song1, Dong Hyun Lee1, Hwiwoo Kim1, Jongpil Lee1, Sangmin Lee1, Donghyun Ahn1, Sungchan Park2, Kun Suk Kim1.
Abstract
Purpose: We aimed to determine the impact of de novo vesicoureteral reflux (VUR) on postoperative urinary tract infection (UTI) and renal function in pediatric patients with ureteroceles. Materials andEntities:
Keywords: Endoscopy; Punctures; Ureterocele; Urinary tract infections; Vesico-ureteral reflux
Year: 2019 PMID: 31294139 PMCID: PMC6607067 DOI: 10.4111/icu.2019.60.4.295
Source DB: PubMed Journal: Investig Clin Urol ISSN: 2466-0493
Fig. 1Schematic images of the endoscopic ureterocele puncture technique. (A) A large, single puncture was made with a 5 Fr Bugbee electrode at the intravesical, inferomedial portion of the ureterocele just above the bladder neck. (B) Small, multiple punctures were made at two or more sites using a 2 Fr Bugbee electrode at the inferomedial portion of the ureterocele until the ureterocele decompressed securely.
Preoperative clinical parameters
| Parameter | Total | Single system | Duplication | p-value |
|---|---|---|---|---|
| Number of renal units | 36 (100.0) | 14 (38.9) | 22 (61.1) | |
| Age (mo) | 3 (1–11) | 7 (1–85.2) | 2 (1–5.2) | 0.192 |
| Sex (male:female) | 9:27 | 7:7 | 2:20 | 0.014 |
| Side (right:left) | 19:17 | 8:6 | 11:11 | 0.742 |
| Prenatal diagnosis | 27 (75.0) | 20 (74.1) | 7 (31.8) | 0.111 |
| Presentation | 0.378 | |||
| Antenatal diagnosis | 20 (55.6) | 7 (50.0) | 13 (59.1) | |
| Urinary tract infection | 12 (33.3) | 4 (28.6) | 8 (36.4) | |
| Voiding difficulty | 4 (11.1) | 3 (21.4) | 1 (4.5) | |
| Size >1/3 of bladder | 18 (50.0) | 6 (42.9) | 12 (54.5) | 0.733 |
| Extent of ureterocele | 0.054 | |||
| Intravesical | 26 (72.2) | 13 (92.9) | 13 (59.1) | |
| Extravesical | 10 (27.8) | 1 (7.1) | 9 (40.9) | |
| Preoperative hydronephrosis (SFU grade) | <0.001 | |||
| 0 | 1 (2.8) | 1 (7.1) | 0 (0.0) | |
| 1 | 2 (5.6) | 1 (7.1) | 1 (4.5) | |
| 2 | 4 (11.1) | 3 (21.4) | 1 (4.5) | |
| 3 | 7 (19.4) | 6 (42.9) | 1 (4.5) | |
| 4 | 22 (61.1) | 3 (21.4) | 19 (86.4) | |
| Preoperative VUR | ||||
| None | 27 (75.0) | 11 (78.6) | 16 (72.7) | 1.000 |
| Single-system ipsilateral VUR | 1 (2.8) | 1 (7.1) | - | |
| Duplication ipsilateral upper moiety VUR | 1 (2.8) | - | 1 (4.5) | |
| Duplication ipsilateral lower moiety VUR | 4 (11.1) | - | 4 (18.2) | |
| Contralateral VUR | 4 (11.1) | 2 (14.3) | 2 (9.1) | 0.634 |
| Preoperative renal function | 47.1 (37.0–50.1) | 48.4 (21.8–49.8) | 44.6 (37.0–51.0) | 0.716 |
Values are presented as number (%), median (interquartile range), or number only.
SFU, Society for Fetal Urology; VUR, vesicoureteral reflux.
Clinical outcomes in patients with single and duplicated systems
| Parameter | Total | Single system | Duplication | p-value |
|---|---|---|---|---|
| Number of renal units | 36 (100.0) | 14 (38.9) | 22 (61.1) | |
| Follow-up periods (mo) | 36 (19.25–66.50) | 33.5 (16.7–48.2) | 50.5 (18.5–89.5) | 0.236 |
| Decompression of hydronephrosis | 28 (77.8) | 13 (92.9) | 15 (68.2) | 0.115 |
| Postoperative hydronephrosis (SFU grade) | 0.487 | |||
| 0 | 19 (52.8) | 9 (64.3) | 10 (45.5) | |
| 1 | 5 (13.9) | 2 (14.3) | 3 (13.6) | |
| 2 | 5 (13.9) | 2 (14.3) | 3 (13.6) | |
| 3 | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| 4 | 7 (19.4) | 1 (7.1) | 6 (27.3) | |
| Postoperative VUR | ||||
| None | 12 (33.3) | 7 (50.0) | 5 (22.7) | 0.148 |
| Single-system ipsilateral VUR | 6 (16.7) | 6 (42.9) | - | |
| Duplication, ipsilateral upper moiety VUR | 14 (38.9) | - | 14 (63.6) | |
| Duplication, ipsilateral lower moiety VUR | 6 (16.7) | - | 6 (27.3) | |
| Contralateral | 4 (11.1) | 2 (14.3) | 2 (9.1) | |
| | 18 (50.0) | 5 (35.7) | 13 (59.1) | 0.305 |
| Newly appeared lower moiety VUR | 2 (5.6) | - | 2 (9.1) | |
| Persisting lower | 4 (11.0) | - | 4 (18.2) | |
| Postoperative relative renal function | 45.4 (38.1–50.0) | 44.6 (35.7–51.0) | 47.3 (46.3–50.0) | 0.421 |
| Postoperative UTI | 15 (41.7) | 3 (21.4) | 12 (54.5) | 0.083 |
| Secondary operation | 11 (30.6) | 2 (14.3) | 9 (40.9) | 0.142 |
| Primary success | 22 (61.1) | 12 (85.7) | 10 (45.5) | 0.033 |
| Renal functional deterioration | 4 (11.1) | 0 (0.0) | 4 (18.2) | 0.141 |
Values are presented as number (%) or median (interquartile range).
SFU, Society for Fetal Urology; UTI, urinary tract infection; VUR, vesicoureteral reflux.
Univariate and multivariate logistic regression analysis of surgical outcomes in the study patients
| Primary success | Preop UTI | Secondary operation | Renal function decrease | |||||
|---|---|---|---|---|---|---|---|---|
| OR | p-value | OR | p-value | OR | p-value | OR | p-value | |
| Duplication | 0.139 | 0.024 | 4.400 | 0.057 | 4.154 | 0.105 | 3.590E8 | 0.999 |
| Preop VUR | 1.048 | 0.764 | 1.164 | 0.845 | 0.213 | 0.172 | 0.000 | 0.999 |
| Preop contralateral VUR | 2.053 | 0.552 | 0.429 | 0.483 | 0.733 | 0.799 | 0.000 | 0.999 |
| Puncture technique | 2.800 | 0.248 | 0.625 | 0.560 | 0.571 | 0.534 | 0.000 | 0.999 |
| De novo VUR | 1.000 | 1.000 | 0.795 | 0.735 | 1.300 | 0.718 | 3.400 | 0.311 |
| Newly appeared lower moiety VUR | 1.222 | 0.892 | 0.818 | 0.892 | 1.500 | 0.785 | 0.000 | 0.999 |
UTI, urinary tract infection; OR, odds ratio; preop, preoperative; VUR, vesicoureteral reflux.
Indications for secondary surgery and the selected surgical methods after endoscopic puncture of ureterocele
| Indication for secondary surgery | Surgical method | Number of renal units |
|---|---|---|
| High-grade VUR and recurrent UTIs | Reimplantation | 3 |
| Bulking agent injection and reimplantation | 1 | |
| Not decompressed ureterocele with recurrent UTI and decreased renal function | Re-puncture and reimplantation | 1 |
| Not decompressed ureterocele | Re-puncture | 1 |
| Not decompressed ureterocele with nonfunctioning upper moiety, recurrent UTI and high-grade VUR | Re-puncture and laparoscopic heminephrectomy and reimplantation | 1 |
| Nonfunctioning upper moiety and recurrent UTI | Upper and lower urinary tract surgery | 2 |
VUR, vesicoureteral reflux; UTI, urinary tract infection.